儿童新冠后遗症的神经学方面
Neurological Aspects of the Sequelae of COVID-19 in Children.
作者信息
Nemkova S A
机构信息
Pirogov Russian National Research Medical University, Moscow, Russia.
出版信息
Neurosci Behav Physiol. 2022;52(8):1169-1176. doi: 10.1007/s11055-023-01344-5. Epub 2023 Feb 15.
Abstract
It has now been established that neurological and neuropsychiatric disorders persist for prolonged periods in a significant proportion of adult patients who have had COVID-19, though there is much less information about the manifestations of post-COVID syndrome (PCS) in children and adolescents. This review presents data on the features of the course of PCS in young patients, and considers the options for treating these patients. The results of studies on the use of Cortexin for correcting cognitive and emotional disorders are analyzed.
摘要
现已确定，相当一部分感染过新冠病毒的成年患者中，神经和神经精神疾病会长期存在，不过关于儿童和青少年新冠后综合征（PCS）表现的信息要少得多。本综述介绍了年轻患者中PCS病程的特点数据，并探讨了治疗这些患者的方法。分析了使用Cortexin纠正认知和情绪障碍的研究结果。
相似文献
1
Neurological Aspects of the Sequelae of COVID-19 in Children.儿童新冠后遗症的神经学方面
Neurosci Behav Physiol. 2022;52(8):1169-1176. doi: 10.1007/s11055-023-01344-5. Epub 2023 Feb 15.
2
[Neurological aspects of the consequences of COVID-19 in children].[新冠病毒疾病（COVID-19）对儿童影响的神经学方面]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(4):23-30. doi: 10.17116/jnevro202212204123.
3
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.新冠后综合征患病率的测定及药物皮质素治疗新冠后综合征患者神经障碍的有效性评估。CORTEX多中心临床与流行病学观察项目的结果
Neurosci Behav Physiol. 2022;52(6):836-841. doi: 10.1007/s11055-022-01307-2. Epub 2022 Oct 26.
4
[Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].[新冠后综合征患病率的测定及药物Cortexin治疗新冠后综合征患者神经障碍有效性的评估。多中心临床和流行病学观察项目CORTEX的结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):84-90. doi: 10.17116/jnevro202212201184.
5
[Post-COVID syndrome in the neurological practice].[神经科实践中的新冠后综合征]
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7):124-129. doi: 10.17116/jnevro2023123071124.
6
[Neurological disorders in the postcovid period].[新冠疫情后时期的神经系统疾病]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(10):31-37. doi: 10.17116/jnevro202212210131.
7
[Neurological manifestations of postcovid syndrome].[新冠后综合征的神经学表现]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(3):7-15. doi: 10.17116/jnevro20221220317.
8
DETERMINATION OF SOMATIC, NEUROLOGICAL AND PSYCHO-EMOTIONAL MANIFESTATIONS OF THE ACUTE AND POSTCOVID PERIOD IN PATIENTS WITH A MILD COURSE OF COVID-19 IN WARTIME.在战时，确定患有轻度 COVID-19 的患者在急性和新冠后时期的躯体、神经和心理-情绪表现。
Wiad Lek. 2023;76(5 pt 2):1160-1166. doi: 10.36740/WLek202305204.
9
[The use of neurotropic therapy in young patients with postcovid syndrome].[神经营养疗法在新冠后综合征年轻患者中的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(3):126-130. doi: 10.17116/jnevro2022122031126.
10
Neurological Signs of Postcovid Syndrome.新冠后综合征的神经学体征。
Neurosci Behav Physiol. 2022;52(7):968-975. doi: 10.1007/s11055-022-01324-1. Epub 2022 Dec 24.
引用本文的文献
1
Risk Factors for Persistent Anosmia and Dysgeusia in Children with SARS-CoV-2 Infection: A Retrospective Study.新冠病毒感染儿童持续性嗅觉丧失和味觉障碍的危险因素：一项回顾性研究
Children (Basel). 2023 Mar 21;10(3):597. doi: 10.3390/children10030597.
本文引用的文献
1
Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence From a Household Cohort Study in England and Wales.新冠疫情期间儿童持续症状的患病率及特征：来自英格兰和威尔士一项家庭队列研究的证据
Pediatr Infect Dis J. 2022 Dec 1;41(12):979-984. doi: 10.1097/INF.0000000000003715. Epub 2022 Oct 21.
2
Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children.儿童长新冠疾病的临床特征、活动水平和心理健康问题：对 510 名儿童的调查。
Future Microbiol. 2022 May;17(8):577-588. doi: 10.2217/fmb-2021-0285. Epub 2022 Apr 1.
3
Post COVID-19 neurological complications; a meta-analysis.新冠病毒感染后神经系统并发症；一项荟萃分析。
Ann Med Surg (Lond). 2022 Apr;76:103440. doi: 10.1016/j.amsu.2022.103440. Epub 2022 Mar 3.
4
Neurological effects of COVID-19 in infants and children.COVID-19 对婴幼儿的神经系统影响。
Dev Med Child Neurol. 2022 Jul;64(7):818-829. doi: 10.1111/dmcn.15185. Epub 2022 Mar 3.
5
[Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].[新冠后综合征患病率的测定及药物Cortexin治疗新冠后综合征患者神经障碍有效性的评估。多中心临床和流行病学观察项目CORTEX的结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):84-90. doi: 10.17116/jnevro202212201184.
6
How Common is Long COVID in Children and Adolescents?儿童和青少年中长新冠的发病率有多高？
Pediatr Infect Dis J. 2021 Dec 1;40(12):e482-e487. doi: 10.1097/INF.0000000000003328.
7
A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection.合并感染新型冠状病毒2（SARS-CoV-2）的儿科患者严重神经表现的系统评价
Neurol Int. 2021 Aug 17;13(3):410-427. doi: 10.3390/neurolint13030041.
8
Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study).长新冠与儿童和青少年的身心健康：全国匹配队列研究方案（CLoCk 研究）。
BMJ Open. 2021 Aug 26;11(8):e052838. doi: 10.1136/bmjopen-2021-052838.
9
SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis.SARS-CoV-2 感染小儿大脑皮层神经元：转录组分析及 Toll 样受体在发病机制中的潜在作用。
Int J Mol Sci. 2021 Jul 28;22(15):8059. doi: 10.3390/ijms22158059.
10
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.在英国有症状的学龄儿童中，对 SARS-CoV-2 进行检测，分析其患病持续时间和症状特征。
Lancet Child Adolesc Health. 2021 Oct;5(10):708-718. doi: 10.1016/S2352-4642(21)00198-X. Epub 2021 Aug 3.
Zotero 插件